The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Blood and blood components (including haematopoietic progenitor cells ), are regulated under the Therapeutic Goods Act 1989 as medicines. Plasma-derived medical products are regulated as prescription medicines.